Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease

<div>The UHPLC-QqQ-MS analysis of the HQT. (a) The UHPLC-QqQ-MS analysis of standard reference materials. Epicatechin (S1), nuciferine (S2), typhaneoside (S3), rutin (S4), heterosine lisu-3-o-new hesperidin (S5), hyperoside (S6), isoquercetin (S7), notoginsenoside R1 (S8), quercetin (S9), isorhamnetin (S10), alisol A 24-acetate (S11), and 23-O-acetylalisol B (S12). (b) The UHPLC-QqQ-MS analysis of the HQT.</div>

Oxidative Medicine and Cellular Longevity

fig1

Figure 1

Figure 1: Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease 

Figure 1 | Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease 